The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …

The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …

The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …

We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …

Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting
enzyme 2 (ACE2) 1 , could represent a new chemoprophylactic approach for …

SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …

The SARS-CoV-2 B. 1.617. 2 (Delta) variant was first identified in the state of Maharashtra in
late 2020 and spread throughout India, outcompeting pre-existing lineages including B. …

Tetherin is an IFN-inducible restriction factor that inhibits HIV-1 particle release in the
absence of the HIV-1 countermeasure, viral protein U (Vpu). Although ubiquitous in HIV-1 and …

The Human Silencing Hub (HUSH) complex is necessary for epigenetic repression of LINE-1
elements. We show that HUSH-depletion in human cell lines and primary fibroblasts leads …

The SARS-CoV-2 Omicron BA.1 variant emerged in late 2021 and is characterised by
multiple spike mutations across all spike domains. Here we show that compared to the Delta …